Atlas Trials

Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer

Clinical trial NCT01938573 · COMPLETED

Trial details

NCT number
NCT01938573
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent Bladder CarcinomaStage II Bladder CancerStage III Bladder CancerStage IV Bladder Cancer
Start date
2013-10-01
Primary completion
2016-08-18
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.